Last --
Change Today 0.00 / 0.00%
Volume 0.0
All times are local (Market data is delayed by at least 15 minutes).

enhance biotech inc (EBOI) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
55.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ENHANCE BIOTECH INC (EBOI)

Related News

No related news articles were found.

enhance biotech inc (EBOI) Related Businessweek News

No Related Businessweek News Found

enhance biotech inc (EBOI) Details

Enhance Biotech, Inc., a development stage company, engages in the acquisition, development, and commercialization of therapeutic drugs. Its product pipeline includes 13 products under development in three main groups: Urology, Dermatology, and Central Nervous System disorders. The company’s Urology products include LI-301 for the delay of ejaculation in men and DPI-221 for urinary incontinence. Its Dermatology products include LI-303 for cellulite, LI-312 for psoriasis and atopic dermatitis, LI-412 for eczema/itch, and LI-236 for anti-aging. The company is also developing drugs for treating Central Nervous System disorders, including cDPI-125 for moderate to severe pain, DPI-289 for depression, and DPI-290 for Parkinson’s disease. Its other products under development to license include LI-401 for the treatment of gingivitis and periodontitis in humans and animals; LI-316 [Stimulant] and LI-316[Inhibitor] for human male and animal fertility enhancement; and ARD-353 for cardiovascular disease. The company is headquartered in Durham, North Carolina.

15 Employees
Last Reported Date: 07/5/05

enhance biotech inc (EBOI) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: --
Chief Financial Officer
Total Annual Compensation: --
Chief Science Officer and President of Asia P...
Total Annual Compensation: --
Chief Science Officer and Vice President of S...
Total Annual Compensation: --
Secretary
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EBOI:US $0.00 USD 0.00

EBOI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for EBOI.
View Industry Companies
 

Industry Analysis

EBOI

Industry Average

Valuation EBOI Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENHANCE BIOTECH INC, please visit www.enhancebiotech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.